Arturo Casadevall

InstitutionDepartment of Molecular Microbiology and Immunology
AddressBaltimore
Maryland
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 39 Covid-19 publications, with a maximum of 4 publications in July 2020 and November 2020 and April 2021 and August 2021
    All Publications
    Bar chart showing 507 publications over 20 distinct years, with a maximum of 36 publications in 2009
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Citations: 6     Fields:    Translation:Humans
    2. Focosi D, Franchini M, Pirofski LA, Burnouf T, Fairweather D, Joyner MJ, Casadevall A. COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8). PMID: 34452459.
      Citations:    Fields:    Translation:HumansCells
    3. Casadevall A, Weiss SR, Imperiale MJ. Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic? mBio. 2021 08 31; 12(4):e0194821. PMID: 34334001.
      Citations: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    4. Casadevall A, Joyner MJ, Pirofski LA. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy. Clin Infect Dis. 2021 08 02; 73(3):e540-e542. PMID: 32805024.
      Citations: 2     Fields:    Translation:Humans
    5. Klassen SA, Senefeld JW, Senese KA, Johnson PW, Wiggins CC, Baker SE, van Helmond N, Bruno KA, Pirofski LA, Shoham S, Grossman BJ, Henderson JP, Wright RS, Fairweather D, Paneth NS, Carter RE, Casadevall A, Joyner MJ. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151. PMID: 34164419.
      Citations: 7     
    6. Casadevall A, Dragotakes Q, Johnson PW, Senefeld JW, Klassen SA, Wright RS, Joyner MJ, Paneth N, Carter RE. Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality. Elife. 2021 06 04; 10. PMID: 34085928.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    7. Senefeld JW, Klassen SA, Ford SK, Senese KA, Wiggins CC, Bostrom BC, Thompson MA, Baker SE, Nicholson WT, Johnson PW, Carter RE, Henderson JP, Hartman WR, Pirofski LA, Wright RS, Fairweather L, Bruno KA, Paneth NS, Casadevall A, Joyner MJ. Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion. 2021 08; 61(8):2503-2511. PMID: 34036587.
      Citations: 9     Fields:    Translation:Humans
    8. Nguyen NK, Burnham CD, Casadevall A, Estes MK, Ferrell RV, Fleiszig SMJ. Microbial Science Research in the Post-COVID Environment. mBio. 2021 06 29; 12(3):e0111621. PMID: 34044593.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Natarajan H, Crowley AR, Butler SE, Xu S, Weiner JA, Bloch EM, Littlefield K, Wieland-Alter W, Connor RI, Wright PF, Benner SE, Bonny TS, Laeyendecker O, Sullivan D, Shoham S, Quinn TC, Larman HB, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Ackerman ME. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. mBio. 2021 04 20; 12(2). PMID: 33879585.
      Citations: 10     Fields:    Translation:Humans
    10. Casadevall A, Henderson JP, Joyner MJ, Pirofski LA. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities. J Clin Invest. 2021 04 01; 131(7). PMID: 33621214.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    11. Morgenlander WR, Henson SN, Monaco DR, Chen A, Littlefield K, Bloch EM, Fujimura E, Ruczinski I, Crowley AR, Natarajan H, Butler SE, Weiner JA, Li MZ, Bonny TS, Benner SE, Balagopal A, Sullivan D, Shoham S, Quinn TC, Eshleman SH, Casadevall A, Redd AD, Laeyendecker O, Ackerman ME, Pekosz A, Elledge SJ, Robinson M, Robinson M, Tobian AA, Larman HB. Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. J Clin Invest. 2021 04 01; 131(7). PMID: 33571169.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    12. Spellberg B, Nielsen TB, Casadevall A. Antibodies, Immunity, and COVID-19. JAMA Intern Med. 2021 04 01; 181(4):460-462. PMID: 33231673.
      Citations: 6     Fields:    Translation:Humans
    13. Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, Casadevall A, Devine DV, Dunbar NM, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Beaudoin G, Tobian AAR. COVID-19 convalescent plasma: Interim recommendations from the AABB. Transfusion. 2021 04; 61(4):1313-1323. PMID: 33586160.
      Citations: 9     Fields:    Translation:Humans
    14. Casadevall A, Pirofski LA, Joyner MJ. The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19. mBio. 2021 03 02; 12(2). PMID: 33653885.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    15. Kared H, Redd AD, Bloch EM, Bonny TS, Sumatoh H, Kairi F, Carbajo D, Abel B, Newell EW, Bettinotti MP, Benner SE, Patel EU, Littlefield K, Laeyendecker O, Shoham S, Sullivan D, Casadevall A, Pekosz A, Nardin A, Fehlings M, Tobian AA, Quinn TC. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. J Clin Invest. 2021 03 01; 131(5). PMID: 33427749.
      Citations: 44     Fields:    Translation:HumansCells
    16. Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser J, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski LA, Baker SE, van Helmond N, Wright RS, Fairweather D, Bruno KA, Wang Z, Paneth NS, Casadevall A, Joyner MJ. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1262-1275. PMID: 33958057.
      Citations: 35     Fields:    Translation:Humans
    17. Ripoll JG, van Helmond N, Senefeld JW, Wiggins CC, Klassen SA, Baker SE, Larson KF, Murphy BM, Andersen KJ, Ford SK, Casadevall A, Joyner MJ. Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19. Clin Microbiol Newsl. 2021 Feb 15; 43(4):23-32. PMID: 33564204.
      Citations: 8     
    18. Casadevall A, Tobian AAR. Convalescent plasma for COVID-19 - encouraging signals of efficacy. Br J Haematol. 2021 02; 192(4):681-682. PMID: 33524158.
      Citations:    Fields:    Translation:Humans
    19. Bloch EM, Patel EU, Marshall C, Littlefield K, Goel R, Grossman BJ, Winters JL, Shrestha R, Burgess I, Laeyendecker O, Shoham S, Sullivan D, Gehrie EA, Redd AD, Quinn TC, Casadevall A, Pekosz A, Tobian AAR. ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population. Vox Sang. 2021 Aug; 116(7):766-773. PMID: 33493365.
      Citations: 5     Fields:    Translation:Humans
    20. Patel EU, Bloch EM, Clarke W, Hsieh YH, Boon D, Eby Y, Fernandez RE, Baker OR, Keruly M, Kirby CS, Klock E, Littlefield K, Miller J, Schmidt HA, Sullivan P, Piwowar-Manning E, Shrestha R, Redd AD, Rothman RE, Sullivan D, Shoham S, Casadevall A, Quinn TC, Pekosz A, Tobian AAR, Laeyendecker O. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers. J Clin Microbiol. 2021 01 21; 59(2). PMID: 33139419.
      Citations: 49     Fields:    Translation:Humans
    21. Citations: 127     Fields:    Translation:Humans
    22. Casadevall A, Joyner MJ, Pirofski LA. Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. N Engl J Med. 2021 01 14; 384(2):189. PMID: 33378610.
      Citations: 5     Fields:    Translation:Humans
    23. Casadevall A, Grossman BJ, Henderson JP, Joyner MJ, Shoham S, Pirofski LA, Paneth N. The Assessment of Convalescent Plasma Efficacy against COVID-19. Med (N Y). 2020 Dec 18; 1(1):66-77. PMID: 33363284.
      Citations: 9     
    24. Bonny TS, Patel EU, Zhu X, Bloch EM, Grabowski MK, Abraham AG, Littlefield K, Shrestha R, Benner SE, Laeyendecker O, Shoham S, Sullivan D, Quinn TC, Casadevall A, Pekosz A, Redd AD, Tobian AAR. Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa574. PMID: 33553467.
      Citations: 8     
    25. Benner SE, Patel EU, Laeyendecker O, Pekosz A, Littlefield K, Eby Y, Fernandez RE, Miller J, Kirby CS, Keruly M, Klock E, Baker OR, Schmidt HA, Shrestha R, Burgess I, Bonny TS, Clarke W, Caturegli P, Sullivan D, Shoham S, Quinn TC, Bloch EM, Casadevall A, Tobian AAR, Redd AD. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors. J Infect Dis. 2020 11 13; 222(12):1974-1984. PMID: 32910175.
      Citations: 29     Fields:    Translation:Humans
    26. Casadevall A, Pirofski LA. In fatal COVID-19, the immune response can control the virus but kill the patient. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30009-30011. PMID: 33177233.
      Citations: 7     Fields:    Translation:HumansCells
    27. Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh MJ, Shrestha R, Wu AA, Hughes RM, Burgess I, Caturegli P, Laeyendecker O, Quinn TC, Sullivan D, Shoham S, Redd AD, Bloch EM, Casadevall A, Tobian AA. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020 11 02; 130(11):6141-6150. PMID: 32764200.
      Citations: 151     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    28. Casadevall A, Joyner MJ, Pirofski LA. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Invest. 2020 10 01; 130(10):5112-5114. PMID: 32634126.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    29. Liu STH, Lin HM, Baine I, Wajnberg A, Gumprecht JP, Rahman F, Rodriguez D, Tandon P, Bassily-Marcus A, Bander J, Sanky C, Dupper A, Zheng A, Nguyen FT, Amanat F, Stadlbauer D, Altman DR, Chen BK, Krammer F, Mendu DR, Firpo-Betancourt A, Levin MA, Bagiella E, Casadevall A, Cordon-Cardo C, Jhang JS, Arinsburg SA, Reich DL, Aberg JA, Bouvier NM. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020 11; 26(11):1708-1713. PMID: 32934372.
      Citations: 167     Fields:    Translation:HumansPHPublic Health
    30. Citations: 170     Fields:    Translation:HumansCellsPHPublic Health
    31. Imperiale MJ, Casadevall A. Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic. mBio. 2020 08 07; 11(4). PMID: 32769091.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    32. Casadevall A, Joyner MJ, Pirofski LA. A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. JAMA. 2020 08 04; 324(5):455-457. PMID: 32492105.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    33. Citations: 130     Fields:    Translation:HumansPHPublic Health
    34. Bergman A, Sella Y, Agre P, Casadevall A. Oscillations in U.S. COVID-19 Incidence and Mortality Data Reflect Diagnostic and Reporting Factors. mSystems. 2020 Jul 14; 5(4). PMID: 32665331.
      Citations: 9     
    35. Pirofski LA, Casadevall A. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework. mBio. 2020 07 02; 11(4). PMID: 32616514.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    36. Schloss PD, Junior M, Alvania R, Arias CA, Baumler A, Casadevall A, Detweiler C, Drake H, Gilbert J, Imperiale MJ, Lovett S, Maloy S, McAdam AJ, Newton ILG, Sadowsky M, Sandri-Goldin RM, Silhavy TJ, Tontonoz P, Young JH, Cameron CE, Cann I, Oveta Fuller A, Kozik AJ. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Spectr. 2020 07; 8(3). PMID: 32737963.
      Citations:    Fields:    Translation:Humans
    37. Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765. PMID: 32254064.
      Citations: 312     Fields:    Translation:HumansCellsPHPublic Health
    38. Ahima RS, Jackson S, Casadevall A, Semenza GL, Tomaselli G, Collins KL, Lieberman AP, Martin DM, Reddy P. Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic. J Clin Invest. 2020 05 01; 130(5):2147. PMID: 32202513.
      Citations: 5     Fields:    Translation:PHPublic Health
    39. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 04 01; 130(4):1545-1548. PMID: 32167489.
      Citations: 352     Fields:    Translation:HumansCellsPHPublic Health
    40. Imperiale MJ, Casadevall A. Vagueness and costs of the pause on gain-of-function (GOF) experiments on pathogens with pandemic potential, including influenza virus. mBio. 2014 Dec 12; 5(6). PMID: 25505121.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    41. Casadevall A, Shenk T. mBio addresses the pause in gain-of-function (GOF) experiments involving pathogens with pandemic potential (PPP). mBio. 2014 Dec 12; 5(6). PMID: 25505126.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    Casadevall's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (382)
    Explore
    _
    Co-Authors (251)
    Explore
    _
    Similar People (60)
    Explore
    _